← Insider buys
STML

Stemline Therapeutics Inc

COO Kenneth Hoberman sold $368K of Stemline Therapeutics Inc

Sold$368,409
$14.27Price
25,817Shares
−3%Stake

What STML did after the filing

Prices for STML after this filing aren't in yet.

Traded Tue, May 14. Filed Fri, May 17, 5:29 PM ET, after the close. Not investment advice.